Flash Forward is a show about possible (and not so possible) future scenarios. What would the warranty on a sex robot look like? How would diplomacy work if we couldn’t lie? Could there ever be a fecal transplant black market? (Complicated, it wouldn’t, and yes, respectively, in case you’re curious.) Hosted and produced by award winning science journalist Rose Eveleth, each episode combines audio drama and journalism to go deep on potential tomorrows, and uncovers what those futures might re ...
…
continue reading
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
QUICKTIME•Episode home
Manage episode 485696608 series 2530615
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Featuring an interview with Dr Rafael Fonseca, including the following topics:
- Safe management of bispecific antibodies and chimeric antigen receptor (CAR) T-cell therapy for patients with multiple myeloma (MM) (0:00)
- Sequencing bispecific antibodies and CAR T-cell therapy (10:40)
- Available data with and potential future clinical integration of belantamab mafodotin in the management of MM (16:03)
- Optimizing maintenance therapy for patients with MM (31:11)
- Novel management strategies for smoldering myeloma (36:29)
- Role of anti-CD38 antibodies in the up-front management of MM (41:41)
- Available data with cereblon E3 ligase modulatory drugs for MM (47:45)
1510 episodes
QUICKTIME•Episode home
Manage episode 485696608 series 2530615
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Featuring an interview with Dr Rafael Fonseca, including the following topics:
- Safe management of bispecific antibodies and chimeric antigen receptor (CAR) T-cell therapy for patients with multiple myeloma (MM) (0:00)
- Sequencing bispecific antibodies and CAR T-cell therapy (10:40)
- Available data with and potential future clinical integration of belantamab mafodotin in the management of MM (16:03)
- Optimizing maintenance therapy for patients with MM (31:11)
- Novel management strategies for smoldering myeloma (36:29)
- Role of anti-CD38 antibodies in the up-front management of MM (41:41)
- Available data with cereblon E3 ligase modulatory drugs for MM (47:45)
1510 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.